Are dendritic cells a potential tool for mastitis vaccine development?
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F23%3A43923000" target="_blank" >RIV/62156489:43210/23:43923000 - isvavai.cz</a>
Výsledek na webu
<a href="https://doi.org/10.55251/jmbfs.9839" target="_blank" >https://doi.org/10.55251/jmbfs.9839</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.55251/jmbfs.9839" target="_blank" >10.55251/jmbfs.9839</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Are dendritic cells a potential tool for mastitis vaccine development?
Popis výsledku v původním jazyce
Mastitis is one of the main disease causing big economic losses to dairy farmers. This disease is caused mainly by bacteria. Because of not efficient vaccines, there are necessary to develop new immunotherapy of vaccination strategy to reduce this disease in dairy farms. Dendritic cells are antigen-presenting cells which are able to present antigen to lymphocytes. They are able to induce activation of T naïve lymphocytes. Dendritic cells were used for development of dendritic cell-based anti-tumor vaccines. Development of vaccines against bovine mastitis has many limitations as high number of various pathogens that are able to cause inflammation of mammary gland in cattle; absence of mucus barrier in mammary gland; reduced phagocytic efficiency because of casein and fat globules etc. To this day, it is not available vaccine against bovine mastitis with high efficiency. Development of new immunotherapy or vaccine against mastitis would be very desirable. In this mini review, we are considering possibilities for development of new dendritic cell-based vaccine against bovine mastitis.
Název v anglickém jazyce
Are dendritic cells a potential tool for mastitis vaccine development?
Popis výsledku anglicky
Mastitis is one of the main disease causing big economic losses to dairy farmers. This disease is caused mainly by bacteria. Because of not efficient vaccines, there are necessary to develop new immunotherapy of vaccination strategy to reduce this disease in dairy farms. Dendritic cells are antigen-presenting cells which are able to present antigen to lymphocytes. They are able to induce activation of T naïve lymphocytes. Dendritic cells were used for development of dendritic cell-based anti-tumor vaccines. Development of vaccines against bovine mastitis has many limitations as high number of various pathogens that are able to cause inflammation of mammary gland in cattle; absence of mucus barrier in mammary gland; reduced phagocytic efficiency because of casein and fat globules etc. To this day, it is not available vaccine against bovine mastitis with high efficiency. Development of new immunotherapy or vaccine against mastitis would be very desirable. In this mini review, we are considering possibilities for development of new dendritic cell-based vaccine against bovine mastitis.
Klasifikace
Druh
J<sub>imp</sub> - Článek v periodiku v databázi Web of Science
CEP obor
—
OECD FORD obor
40201 - Animal and dairy science; (Animal biotechnology to be 4.4)
Návaznosti výsledku
Projekt
<a href="/cs/project/QK1910212" target="_blank" >QK1910212: Moderní metody diagnostiky, terapie a prevence mastitid způsobených Streptococcus uberis jako nástroj pro sestavování cílených kontrolních programů v chovech skotu</a><br>
Návaznosti
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Ostatní
Rok uplatnění
2023
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
Journal of Microbiology, Biotechnology and Food Sciences
ISSN
1338-5178
e-ISSN
1338-5178
Svazek periodika
12
Číslo periodika v rámci svazku
4
Stát vydavatele periodika
SK - Slovenská republika
Počet stran výsledku
3
Strana od-do
"e9839"
Kód UT WoS článku
000927017500001
EID výsledku v databázi Scopus
2-s2.0-85147776413